Stockreport

Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Baudax Bio, Inc.  (BXRX) 
PDF MALVERN, Pa., April 03, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today annou [Read more]